N-(2-chlorophenyl)-3-(4-nitro-1H-benzimidazol-2-yl)benzenesulfonamide
C19H13ClN4O4S — CID 142088863
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2-chlorophenyl)-3-(4-nitro-1H-benzimidazol-2-yl)benzenesulfonamide
N-(2-chlorophenyl)-3-(4-nitro-1H-benzimidazol-2-yl)benzenesulfonamide (PubChem CID 142088863) has the molecular formula C19H13ClN4O4S and a molecular weight of 428.86 g/mol. Its IUPAC name is N-(2-chlorophenyl)-3-(4-nitro-1H-benzimidazol-2-yl)benzenesulfonamide.
Molecular Properties
| Compound Name | N-(2-chlorophenyl)-3-(4-nitro-1H-benzimidazol-2-yl)benzenesulfonamide |
|---|---|
| PubChem CID | 142088863 |
| Molecular Formula | C19H13ClN4O4S |
| Molecular Weight | 428.86 g/mol |
| Exact Mass | 428.03 |
| IUPAC Name | N-(2-chlorophenyl)-3-(4-nitro-1H-benzimidazol-2-yl)benzenesulfonamide |
| SMILES | O=[N+]([O-])c1cccc2[nH]c(-c3cccc(S(=O)(=O)Nc4ccccc4Cl)c3)nc12 |
| InChI | InChI=1S/C19H13ClN4O4S/c20-14-7-1-2-8-15(14)23-29(27,28)13-6-3-5-12(11-13)19-21-16-9-4-10-17(24(25)26)18(16)22-19/h1-11,23H,(H,21,22) |
| InChIKey | GERBGRRAUZOAPS-UHFFFAOYSA-N |
| XLogP | 4.59 |
| TPSA | 117.99 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 428.86 |
| LogP ≤ 5 | 4.59 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142088863 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.